Ju Huang

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Anti-cancer immunotherapy is emerging from a nadir and demonstrating tangible benefits to patients. A variety of approaches are now employed. We are invoking antigen (Ag)-specific responses through direct injections of recombinant lentivectors (LVs) that encode sequences for tumor-associated antigens into multiple lymph nodes to optimize immune(More)
  • 1